Korean drug companies urged to explore overseas markets

Published: 2008-07-18 06:56:00

Updated: 2008-07-18 06:56:00

Korean pharmaceutical firms should look to advance into overseas market, amid the government’s relentless price cut and fiercer competition in already saturated domestic market, according to a local analyst.

Analyst Shin Ji-won of Mirae Asset Securities Co. said in a report that the overseas m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK